Usui M - Search Results

1

The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.

Usui Y, Akiba H, Takeuchi M, Kezuka T, Takeuchi A, Hattori T, Okunuki Y, Yamazaki T, Yagita H, Usui M, Okumura K. Usui Y, et al. Among authors: usui m. Eur J Immunol. 2006 Nov;36(11):3071-81. doi: 10.1002/eji.200636138. Eur J Immunol. 2006. PMID: 17039566 Free article.

2

Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.

Usui Y, Okunuki Y, Hattori T, Takeuchi M, Kezuka T, Goto H, Usui M. Usui Y, et al. Among authors: usui m. Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4607-13. doi: 10.1167/iovs.06-0181. Invest Ophthalmol Vis Sci. 2006. PMID: 17003458

3

Blockade of the OX40 ligand prolongs corneal allograft survival.

Hattori T, Usui Y, Okunuki Y, Sonoda Y, Usui M, Takada E, Mizuguchi J, Yagita H, Okumura K, Akiba H, Takeuchi M. Hattori T, et al. Among authors: usui y, usui m. Eur J Immunol. 2007 Dec;37(12):3597-604. doi: 10.1002/eji.200636975. Eur J Immunol. 2007. PMID: 18022861 Free article.

4

CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.

Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, Suzuki J, Okunuki Y, Iwasaki T, Haino M, Matsushima K, Usui M. Takeuchi A, et al. Among authors: usui y, usui m. Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3753-60. doi: 10.1167/iovs.04-1429. Invest Ophthalmol Vis Sci. 2005. PMID: 16186359

5

Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.

Mizuguchi J, Takeuchi M, Usui M. Mizuguchi J, et al. Among authors: usui m. Arch Immunol Ther Exp (Warsz). 2002;50(4):243-54. Arch Immunol Ther Exp (Warsz). 2002. PMID: 12371620 Review.

6

Peritoneal exudate cells treated with calcitonin gene-related peptide suppress murine experimental autoimmune uveoretinitis via IL-10.

Kezuka T, Takeuchi M, Keino H, Usui Y, Takeuchi A, Yamakawa N, Usui M. Kezuka T, et al. Among authors: usui y, usui m. J Immunol. 2004 Jul 15;173(2):1454-62. doi: 10.4049/jimmunol.173.2.1454. J Immunol. 2004. PMID: 15240742

7

Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.

Keino H, Kezuka T, Takeuchi M, Yamakawa N, Hattori T, Usui M. Keino H, et al. Among authors: usui m. Arch Ophthalmol. 2004 Aug;122(8):1179-84. doi: 10.1001/archopht.122.8.1179. Arch Ophthalmol. 2004. PMID: 15302659

8

Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation.

Tsukahara R, Takeuchi M, Akiba H, Kezuka T, Takeda K, Usui Y, Usui M, Yagita H, Okumura K. Tsukahara R, et al. Among authors: usui y, usui m. Int Immunol. 2005 May;17(5):523-30. doi: 10.1093/intimm/dxh234. Epub 2005 Mar 18. Int Immunol. 2005. PMID: 15778288

9

Alpha-internexin as a corneal autoantigen in spontaneous autoimmune keratitis mouse model.

Hattori T, Takeuchi M, Ohno K, Ogawara M, Asatani T, Usui Y, Muramatsu R, Inagaki M, Usui M, Taguchi O. Hattori T, et al. Among authors: usui y, usui m. Invest Ophthalmol Vis Sci. 2006 Jan;47(1):249-55. doi: 10.1167/iovs.05-0774. Invest Ophthalmol Vis Sci. 2006. PMID: 16384970

10

Possibility of inducing anterior chamber-associated immune deviation by TGF-beta2 treatment of monocytes isolated from Behcet's patients.

Takeuchi M, Keino H, Suzuki J, Usui Y, Hattori T, Takeuchi A, Oh-I K, Okunuki Y, Kezuka T, Usui M. Takeuchi M, et al. Among authors: usui y, usui m. Exp Eye Res. 2006 Oct;83(4):981-8. doi: 10.1016/j.exer.2006.05.005. Epub 2006 Jul 5. Exp Eye Res. 2006. PMID: 16822510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters